Skip to Content Skip to Content

Perelman School of Medicine

Visit the School's Site
Reset All Filters
2805 Results
Test predicts which patients with rare blood disease will respond to treatment
David Fajgenbaum in his lab.

David Fajgenbaum is an assistant professor of medicine at the Perelman School of Medicine at the University of Pennsylvania and associate director of patient impact in the Penn Orphan Disease Center. He also leads the Castleman Disease Research Program.

(Image: Courtesy of Penn Medicine)

Test predicts which patients with rare blood disease will respond to treatment

A Penn Medicine study identifies blood proteins that indicate which patients with idiopathic multicentric Castleman disease are most likely to benefit from the only FDA approved treatment for the disease, and uncovers an alternative.

From Penn Medicine News

mRNA COVID-19 vaccines induce T-cell responses in multiple sclerosis patients
Person in full PPE administering a vaccine to another person sittting on a hospital bed.

mRNA COVID-19 vaccines induce T-cell responses in multiple sclerosis patients

Research from Penn Medicine shows mRNA COVID-19 vaccines are effective at inducing T-cell responses in multiple sclerosis patients who receive B cell-depleting Infusions even if their antibody responses are diminished.

From Penn Medicine News

Deborah J. Culley on her vision for the future of Anesthesiology and Critical Care
Deborah Culley standing by a railing at the Perelman School of Medicine in a white lab coat.

Deborah J. Culley, chair of the Department of Anesthesiology and Critical Care. (Image: Penn Medicine News)

Deborah J. Culley on her vision for the future of Anesthesiology and Critical Care

Culley discusses her past research on the connection between anesthesia and post-operative cognitive dysfunction and her new role as chair of the Department of Anesthesiology and Critical Care.

From Penn Medicine News

In hard-hit neighborhoods, Philly CEAL outreach aims to address COVID disparities
A person in a mask holding a clipboard at the bottom of steps outside a home. On the porch are an unmasked adult and two unmasked children.

Image: Courtesy of Penn Medicine Service in Action

In hard-hit neighborhoods, Philly CEAL outreach aims to address COVID disparities

Through community engagement and improved information dissemination, researchers at Penn Nursing, Penn Medicine, and Annenberg, in conjunction with the City of Philadelphia, are working to increase vaccination and testing rates and decrease new COVID-19 infections.

Michele W. Berger

2022 Breakthrough Prize in Life Sciences awarded to mRNA pioneers Drew Weissman and Katalin Karikó
Drew Weissman and Katalin Karikó standing side by side.

Twenty-five years ago, Drew Weissman and Katalin Karikó struck up their first conversations at Penn by a copy machine, where both were printing journal articles. That chance encounter laid the foundation for a revolution in mRNA technology, innovations that are now being leveraged to confront a host of biomedical challenges. (Image: Peggy Peterson)

2022 Breakthrough Prize in Life Sciences awarded to mRNA pioneers Drew Weissman and Katalin Karikó

Weissman and Karikó are honored for engineering modified RNA technology which enabled rapid development of effective COVID-19 vaccines.

Alex Gardner

Choose personal exercise goals, then tackle them immediately
Three people as seen from the ground wearing running shoes on a paved running trail.

Choose personal exercise goals, then tackle them immediately

Research from the Perelman School of Medicine reveals that having people set their own fitness goals and pursue them immediately, rather than giving them assigned goals that begin gradually, is most likely to result in lasting positive change.

From Penn Medicine News